Herpes simplex virus thymidine kinase gene-transfected tumor cells: Sensitivity to antiherpetic drugs

Nucleosides and Nucleotides

Volumn 15, Issue 1-3, 1996, Pages 821-831

  Balzarini, J ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ANTIVIRUS AGENT; BUCICLOVIR; DEOXYURIDINE DERIVATIVE; GANCICLOVIR; GUANINE DERIVATIVE; PENCICLOVIR; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; BRAIN CANCER; BREAST CANCER; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN EXPERIMENT; MOUSE; RAT; REVIEW; TUMOR CELL;

EID: 0029877210     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319608002425     Document Type: Review

References (39)

1. Cheng, Y.-C., Dutschman, G., De Clercq, E., Jones, A.S., Rahim, S.G., Verhelst, G. and Walker, R.T. (1981) Mol. Pharmacol. 20, 230-233.
2. Cheng, Y.-C., Dutschman, G., Fox, J.J., Watanabe, K.A. and Machida, H. (1981) Antimicrob. Agents Chemother. 20, 420-423.
3. Cheng, Y.-C. (1984) In: Antiviral Drugs and Interferon: The Molecular Basis of their Activity. Becker, Y. (ed.). Martinus Nijhoff, Boston, The Hague, pp. 59-70.
4. De Clercq, E. (1984) Biochem. Pharmacol. 33, 2159-2169.
5. De Clercq, E., Descamps, J., De Somer, P., Barr, P.J., Jones, A.S. and Walker, R.T. (1979) Proc. Natl. Acad. Sci. USA 76, 2947-2951.
6. Dyson, M.R., Coe, P.L. and Walker, R.T. (1991) J. Chem. Soc. Chem. Commun. 741-742.
7. Dyson, M.R., Coe, P.L. and Walker, R.T. (1991) J. Med. Chem. 34, 2782-2786.
8. Balzarini, J., Morin, K.W., Knauss, E.E., Wiebe, L.I. and De Clercq, E. (1995) Gene Therapy 2, in press.
9. De Clercq, E., Balzarini, J., Bernaerts, R., Herdewijn, P. and Verbruggen, A. (1985) Biochem. Biophys. Res. Commun. 126, 397-403.
10. Wigerinck, P., Snoeck, R., Claes, P., De Clercq, E. and Herdewijn, P. (1991) J. Med. Chem. 34, 1767-1772.
11. Wigerinck, P., Pannecouque, C., Snoeck, R., Claes, P., De Clercq, E. and Herdewijn, P. (1991) J. Med. Chem. 34, 2383-2389.
12. Balzarini, J., De Clercq, E., Ayusawa, D. and Seno, T. (1985) FEBS Lett. 185, 95-100.
13. Balzarini, J., Bohman, C., Walker, R.T. and De Clercq, E. (1994) Mol. Pharmacol. 45, 1253-1258.
14. Balzarini, J. and De Clercq, E. (1989) Methods Find. Exp. Clin. Pharmacol. 11, 379-389.
15. Bohman, C., Balzarini, J., Wigerinck, P., Van Aerschot, A., Herdewijn P. and De Clercq, E. J. Biol. Chem. 269, 8036-8043.
16. Elion, G.B., Furman, P.A., Fyfe, J.A., de Miranda, P., Beauchamp, L. and Schaeffer, H.J. (1977) Proc. Natl. Acad. Sci. USA 74, 5716-5720.
17. Smee, D.F., Martin, J.C., Verheyden, J.P.H. and Matthews, T.R. (1983) Antimicrob. Agents Chemother. 23, 676-682.
18. Field, A.K., Davies, M.E., De Witt, C., Perry, H.C., Liou, R., Germershausen, J., Karkas, J.D., Ashton, W.T., Johnston, D.B.R. and Tolman, R.L. (1983) Proc. Natl. Acad. Sci. USA 80, 4139-4143.
19. Boyd, M.R., Bacon, T.H., Sutton, D. and Cole, M. (1987) Antimicrob. Agents Chemother. 31, 1238-1242.
20. Norbeck, D.W., Kern, E., Hayashi, S., Rosenbrook, W., Sham, H., Herrin, T., Plattner, J.J., Erickson, J., Clement, J., Swanson, R., Shipkowitz, N., Hardy, D., Marsh, K., Arnett, G., Shannon, W., Broder, S. and Mitsuya, H. (1990) J. Med. Chem. 33, 1285-1288.
21. Fyfe, J.A. (1982) Mol. Pharmacol. 21, 432-437.
22. Nakano, N. (1966) Tohoku J. Exp. Med. 88, 69-84.
23. Koyama, H. and Kodama, H. (1982) Cancer Res. 42, 4210-4214.
24. Ayusawa, D., Shimizu, K., Seno, T., Balzarini, J. and De Clercq, E. (1985) Jpn. J. Cancer Res. 76, 984-988.
25. Shimizu, K., Ren, L., Ayusawa, D., Seno, T., Balzarini, J. and De Clercq, E. (1986) Cell Struct. Funct. 11, 295-301.
26. Balzarini, J., De Clercq, E., Verbruggen, A., Crumpacker, C., Ayusawa, D. and Seno, T. (1986) Anticancer Res. 6, 1077-1084.
27. Balzarini, J., De Clercq, E., Verbruggen, A., Ayusawa, D. and Seno, T. (1985) Mol. Pharmacol. 28, 581-587.
28. Balzarini, J., De Clercq, E., Verbruggen, A., Ayusawa, D., Shimizu, K. and Seno, T. (1987) Mol. Pharmacol. 32, 410-416.
29. De Clercq, E., Balzarini, J., Torrence, P.F., Mertes, M.P., Schmidt, C.L., Shugar, D., Barr, P.J., Jones, A.S., Verhelst, G. and Walker, R.T. (1981) Mol. Pharmacol. 19, 321-330.
30. Balzarini, J. and De Clercq, E. (1984) Biochim. Biophys. Acta 785, 36-45.
31. Balzarini, J., De Clercq, E., Herdewijn, P. and Robins, M.J. (1985) Mol. Pharmacol. 27, 578-583.
32. Santi, D.V. (1980) J. Med. Chem. 23, 103-111.
33. Yokota, Y., Konno, K. and Shigeta, S. (1994) Antiviral Chem. Chemother. 5, 191-194.
34. Cheng, Y.-C., Nakayama, K. and Grill, S.P. (1983) Biochem. Pharmacol. 32, 1407-1410.
35. Balzarini, J., Bohman, C. and De Clercq, E. (1993) J. Biol. Chem. 268, 6332-6337.
36. Culver, K.W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E.H. and Blaese, R.M. (1992) Science 256, 1550-1552.
37. Takamiya, Y., Short, M.P., Ezzeddine, Z.D., Moolten, F.L., Breakefield, X.O. and Martuza, R.L. (1992) J. Neurosc. Res. 33, 493-503.
38. Stone, R. (1992) Science 256, 1513.
39. Desgranges, C., Razaka, G., Rabaud, M., Bricaud, H., Balzarini, J. and De Clercq, E. (1983) Biochem. Pharmacol. 32, 3583-3590.